Indian Army Pharmaceutical Supply Procurement: Critical Oncology and Supportive Care Medications

Work Description - NA

This tender, issued by the Department of Military Affairs under the Ministry of Defence, with Bid Number GEM/2026/B/7849390, is for the procurement of a comprehensive range of pharmaceutical supplies by the Indian Army. The bid is open for submission from August 18, 2026, at 9:39 AM until September 1, 2026, at 10:00 AM. The specific pharmaceutical items required encompass a broad spectrum of critical medications, including but not limited to Cap Crizotinib 250 mg, Rituximab 100mg and 500mg Injectables, Leucovorin Calcium 50mg Injectable, 5-Fluorouracil 500mg 10 ml Injectable, Cabozantinib (40 mg and 60 mg Tablets), Fosaprepitant 150 mg Injectable, Aprepitant (1 Cap 125 mg and 2 Cap 80 mg pack of 3), Cabazitaxel 60 mg Injectable, Megestrolacetate 160 mg Tablets, and combination therapies such as Tegafur, Gimeracil, and Oteracil capsules in various dosages. The tender also includes Bevacizumab 300 mg Injectable, Netupitant 300 mg plus Palonosetron 0.5 mg Tablets, Palonosetron 0.25 mg/ml Injectable, Gemcitabine (200mg and 1000mg Injectables), Capecitabine 500 mg Tablets, and Morphine CR 30 mg Tablets. The total estimated quantity for these items is 86,546 units. Bidders are invited to submit their proposals to the designated office located in Kolkata.